Cytokines and depression: The need for a new paradigm-Reference-Cited by-同舟云学术

Cytokines and depression: The need for a new paradigm

Published:2003-02 Issue:1 Volume:17 Page:119-124
ISSN:0889-1591
Container-title:Brain, Behavior, and Immunity
language:en
Short-container-title:Brain, Behavior, and Immunity

Author:

Capuron Lucile,Dantzer Robert

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology

Reference43 articles.

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders, fourth edition. American Psychiatric Association: Washington, DC

2. Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation;Anisman;Brain Res.,1998

3. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features;Anisman;Mol. Psychiat.,1999

4. Inflammation, depressive symptomtology, and coronary artery disease;Appels;Psychosom. Med.,2000

5. Prediction of the depressive effects of interferon α therapy by the patient’s initial affective state;Capuron;N. Engl. J. Med.,1999

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Common protein networks for various drug regimens of major depression are associated with complement and immunity;Journal of Psychopharmacology;2024-08-16

2. Changes in tryptophan breakdown associated with response to multimodal treatment in depression;Frontiers in Psychiatry;2024-06-21

3. Exploring environmental exposomes and the gut-brain nexus: Unveiling the impact of pesticide exposure;Environmental Research;2024-06

4. Discovery and validation of protein biomarkers for monitoring the effectiveness of drug treatment for major depressive disorder;Journal of Psychiatric Research;2024-01

5. A review of cytokine-based pathophysiology of Long COVID symptoms;Frontiers in Medicine;2023-03-31